美国巴金森氏症深部脑部刺激市场：市场规模、份额、趋势分析（按产品）、竞争分析、细分预测（2025-2030）

美国帕金森氏症深部脑部刺激市场的成长与趋势

根据 Grand View Research, Inc. 的新报告，美国帕金森氏症深部脑部刺激市场规模预计到 2030 年将达到 8.495 亿美元，2025 年至 2030 年的复合年增长率为 7.19%。

这个市场受到多种因素的推动，包括新产品的推出和医疗成本的上涨。不断增加的监管核准在推动市场成长方面发挥关键作用，因为它们为医疗保健专业人员和患者提供了有关这些设备的安全性和有效性的一定程度的保证，从而促进了它们在临床环境中的应用。例如，FDA 于 2024 年 1 月批准雅培的 Liberta RC DBS 设备，标誌着推动 PD治疗性介入的重要里程碑。

Liberta RC DBS 是同类产品中最小的可充电 DBS 设备，并引入了 NeuroSphere Virtual Clinical 等显着的技术特性，可实现远端程式设计功能。此项监管部门的核准凸显了该设备遵守严格的安全性和有效性标准，并将其定位为神经调节领域的先驱解决方案。雅培为 Liberta RC DBS 增加远端程式设计功能，在策略上契合了整体医疗保健趋势，提高了患者的便利性，并扩大了医学界对该设备的接受度。

雅培公司最近获得 FDA 批准的 Liberta RC DBS 预计将改变市场动态，增加美国DBS 领域对 PD 治疗的兴趣和采用。

美国巴金森氏症深部脑部刺激市场：概述

• 双通道部分将在 2024 年以 59.04% 的最大收益占有率引领市场，预计在 2025 年至 2030 年期间将实现最快的复合年增长率。
• 这一增长可归因于技术进步和行业主要企业的新产品推出。
• 推动市场成长的主要因素之一是用于治疗帕金森氏症 (PD) 的深部脑部刺激 (DBS) 设备越来越获得监管机构的核准。
• 监管部门的核准为製造商提供了行销和商业化设备的机会，促进了竞争。
• 这种竞争可能会带来技术进步和设备设计的改进，从而产生更具成本效益的选择，进一步促进市场成长。

目录

第一章 分析方法及范围

第 2 章执行摘要

第 3美国。

• 市场联动展望
  • 附随市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制分析
  • 市场机会
  • 市场挑战
• 美国巴金森氏症深部脑部刺激市场：分析工具
  • 产业分析：波特五力分析
  • PESTEL 分析

第 4美国。

• 细分仪表板
• 美国巴金森氏症深部脑部刺激市场波动
• 美国帕金森氏症深部脑部刺激市场：按产品分類的市场规模和趋势分析（2018-2030 年）
• 单通道
• 双通道

第五章 竞争格局

• 市场参与企业分类
• 主要企业简介
  • ABBOTT
  • Medtronic
  • Boston Scientific Corporation
• 热图分析/企业市场分析
• 各公司市场占有率评估分析分析（2024 年）
• 其他主要企业名单

U.S. Deep Brain Stimulation In Parkinson's Disease Market Growth & Trends:

The U.S. deep brain stimulation in parkinson's disease market size is anticipated to reach USD 849.50 million by 2030, registering a CAGR of 7.19% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by various factors, such as novel product launches, and rising healthcare expenditure. Increasing regulatory approvals play a crucial role in driving market growth as they provide a level of assurance to healthcare professionals and patients regarding the safety and efficacy of these devices, thereby encouraging their adoption in clinical practice. For instance, in January 2024, FDA clearance for Abbott's Liberta RC DBS Device represented a significant milestone in advancing therapeutic interventions for PD.

Liberta RC DBS, distinguished as the smallest rechargeable DBS device in its class, introduced notable technological features, such as the NeuroSphere Virtual Clinical, enabling remote programming capabilities. This regulatory endorsement underscored adherence of the device to stringent safety and efficacy standards and positioned it as a pioneering solution in the field of neuromodulation. The incorporation of remote programming capabilities in the Liberta RC DBS device by Abbott aligns strategically with prevailing healthcare trends, augmenting patient convenience and broadening the device's acceptance within the medical community.

Abbott's recent achievement of securing FDA clearance for Liberta RC DBS is anticipated to catalyze transformative shifts in market dynamics, propelling heightened interest and fostering increased adoption within the U.S. DBS sector for PD treatment.

U.S. Deep Brain Stimulation In Parkinson's Disease Market Report Highlights:

• The dual-channel segment led the market with the largest revenue share of 59.04% in 2024 and is expected to register at the fastest CAGR from 2025 to 2030
• This growth is attributed to technological advancements and novel product launches by industry key players
• One of the key factors driving the market growth is increasing regulatory approval for deep brain stimulation (DBS) devices in Parkinson's disease (PD) treatment
• Regulatory approvals offer opportunities for manufacturers to market and commercialize their devices, fostering competition
• This competition often results in technological advancements, device design improvements, and potentially more cost-effective options, which further contribute to market growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Technological Advancements In Deep Brain Stimulation Devices
    • 3.2.1.2. Increasing Prevalence Of Parkinson's Disease
    • 3.2.1.3. Government Funding For Research And Development
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Complex Regulatory Framework
    • 3.2.2.2. Risk And Complications Associated With DBS Surgery
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Increasing Clinical Studies On DBS Assessments For Parkinson's Disease
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Alternatives For DBS System
• 3.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. U.S. Deep Brain Stimulation In Parkinson's Disease Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Deep Brain Stimulation In Parkinson's Disease Market Movement Analysis
• 4.3. U.S. Deep Brain Stimulation In Parkinson's Disease Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Single-Channel
  • 4.4.1. Single-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Dual-Channel
  • 4.5.1. Dual-Channel U.S. Deep Brain Stimulation In Parkinson's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Key Company Profiles
  • 5.2.1. ABBOTT
    • 5.2.1.1. Company Overview
    • 5.2.1.2. Financial Performance
    • 5.2.1.3. Service Benchmarking
    • 5.2.1.4. Strategic Initiatives
  • 5.2.2. Medtronic
    • 5.2.2.1. Company Overview
    • 5.2.2.2. Financial Performance
    • 5.2.2.3. Service Benchmarking
    • 5.2.2.4. Strategic Initiatives
  • 5.2.3. Boston Scientific Corporation
    • 5.2.3.1. Company Overview
    • 5.2.3.2. Financial Performance
    • 5.2.3.3. Service Benchmarking
    • 5.2.3.4. Strategic Initiatives
• 5.3. Heat Map Analysis/ Company Market Position Analysis
• 5.4. Estimated Company Market Share Analysis, 2024
• 5.5. List of Other Key Market Players

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Deep Brain Stimulation In Parkinson's Disease Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Participant's Overview
• Table 5 Financial Performance
• Table 6 Product Benchmarking
• Table 7 Strategic Initiatives

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 U.S. Deep Brain Stimulation In Parkinson's Disease Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Product Marketplace: Key Takeaways
• Fig. 14 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Single-channel, 2018 - 2030 (USD Million)
• Fig. 15 U.S. Deep Brain Stimulation In Parkinson's Disease Market, for Dual-channel, 2018 - 2030 (USD Million)